Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP) Article Early Access

Ruiz-Patino, Alejandro, Arrieta, Oscar, Cardona, Andres F. et al. (2019). Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP) . THORACIC CANCER, 11(2), 353-361. 10.1111/1759-7714.13272



Open Access International Collaboration

cited authors

  • Ruiz-Patino, Alejandro; Arrieta, Oscar; Cardona, Andres F.; Martin, Claudio; Raez, Luis E.; Zatarain-Barron, Zyanya L.; Barron, Feliciano; Ricaurte, Luisa; Bravo-Garzon, Maria A.; Mas, Luis; Corrales, Luis; Rojas, Leonardo; Lupinacci, Lorena; Perazzo, Florencia; Bas, Carlos; Carranza, Omar; Puparelli, Carmen; Rizzo, Manglio; Ruiz, Rossana; Rolfo, Christian; Archila, Pilar; Rodriguez, July; Sotelo, Carolina; Vargas, Carlos; Carranza, Hernan; Otero, Jorge; Pino, Luis E.; Ortiz, Carlos; Laguado, Paola; Rosell, Rafael; CLICaP

fiu authors

publication date

  • December 12, 2019

webpage

published in

author keyword

category

Digital Object Identifier (DOI)

start page

  • 353

end page

  • 361

volume

  • 11

issue

  • 2